Legal Representation
Attorney
Jeremy D. Spier
USPTO Deadlines
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 12, 2025 | C8.. | O | CANCELLED SEC. 8 (6-YR) | Loading... |
| May 28, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jun 20, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 20, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 20, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 21, 2023 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Oct 28, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Oct 28, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 28, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 28, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 28, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jul 1, 2019 | A7OK | O | AMENDMENT UNDER SECTION 7 - PROCESSED | Loading... |
| Jun 28, 2019 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jun 13, 2019 | ES7R | I | TEAS SECTION 7 REQUEST RECEIVED | Loading... |
| May 28, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 23, 2019 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 22, 2019 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Mar 27, 2019 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Mar 12, 2019 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Mar 27, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 12, 2019 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Nov 13, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 9, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 9, 2018 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Nov 9, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 12, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 10, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 10, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 10, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 18, 2018 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Sep 6, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 4, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 4, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 4, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 13, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 18, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 18, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 29, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 4, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 3, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 8, 2016 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 8, 2016 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 5, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 2, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Additional Information
Translation
The wording "YUTIQ" has no meaning in a foreign language.
Other
In the statement, lines 4-9, is deleted, and "CLASS 5: Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, uveitis and retinal disease; pharmaceutical preparations for the treatment of ocular diseases and conditions, namely, uveitis and retinal disease" is inserted.
Other
The non-Latin characters in the mark transliterate to "YUTIQ" and this has no meaning in a foreign language.